| AD | Alzheimer’s disease |
| ADC | adenocarcinoma |
| AMP | antimicrobial peptide |
| ANT | adenine nucleotide translocator |
| ATP | adenosine triphosphate |
| Bcl-2 | namely B-cell lymphoma 2 |
| Bcl-xL | B-cell lymphoma extra-large |
| Ca2+ | calcium ion |
| Cacy/SIP | calcyclin-binding protein/Siah-1-interacting protein |
| CCL2 | chemokine (C-C motif) ligand 2 |
| COP9 | constitutive photomorphogenesis 9 |
| COPS5 | COP9 constitutive photomorphogenic homolog subunit 5 |
| COX2 | cyclooxygenase-2 |
| CP | calprotectin |
| CRC | colorectal carcinoma |
| CT | computerised tomography |
| Cu2+ | copper ion |
| CXCL | chemokine (C-X-C motif) ligand |
| DAMPs | danger-associated molecular patterns DAMPs |
| ECG | electrocardiogram |
| ECM | extracellular matrix |
| EDC | epidermal differentiation complex |
| EGF | epidermal growth factor |
| EMMPRIN | extracellular matrix metalloprotease inducer |
| EMT | epithelial-mesenchymal transition |
| ERK | extracellular signal-regulated kinase |
| ERα | in estrogen receptor α |
| FABP | fatty acid-binding proteins |
| FAK | focal adhesion kinase |
| FDA | Food and Drug Administration |
| Fe2+ | iron ion |
| HCC | hepatocellular carcinoma |
| HIF-1 | hypoxia-inducible factor 1 |
| IBD | inflammatory bowel disease |
| ICI | intracranial injuries |
| IL-1β | interleukin-1β |
| IFN-γ | interferon gamma |
| Jab1 | c-Jun activation domain-binding protein-1 |
| MAPK | mitogen-activated protein kinase |
| MAP3K8 | mitogen-activated protein kinase kinase kinase 8 |
| MCAM | melanoma cell adhesion molecule |
| MDR1 | multidrug resistance gene 1 |
| Mef2 | myocyte enhancer factor-2 |
| MRP1 | MDR-associated protein 1 |
| miRNA | micro RNA |
| MMP | metalloproteinase |
| Mn2+ | manganese ion |
| mTOR | mechanistic target of rapamycin |
| NCX1 | Na+/Ca2+ exchanger |
| Ndr | nuclear dbf2-related |
| NF-kB | nuclear factor ’kappa-light-chain-enhancer’ of activated B-cells |
| NMIBC | non-muscle-invasive bladder cancer |
| NMIIA | non-muscle myosin heavy chain IIA |
| NOXA | phorbol-12-myristate-13-acetate-induced protein 1 |
| NSCLC | non-small cell lung cancer |
| OS | overall survival |
| OCSC | ovarian cancer stem cells |
| PAD3 | phytoalexin deficient 3 |
| PDGF | platelet-derived growth factor |
| PI3K | phosphoinositide 3-kinase |
| PMCA1b | plasma membrane Ca2+ transport ATPase |
| PUMA | p53 upregulated modulator of apoptosis |
| RA | rheumatoid arthritis |
| RAGE | receptor for advanced glycation end products |
| ROS | reactive oxygen species |
| RSK | ribosomal S6 kinase |
| RyR2 | ryanodine receptor 2 |
| SCC | squamous-cell carcinoma |
| SCLC | small cell lung cancer |
| SERCA2a | sarcoplasmic reticulum ATPase |
| Shh | sonic hedgehog |
| SNC | Scandinavian Neurotrauma Committee |
| STEMI | ST-segment elevation myocardial infarction |
| TAMs | tumour-associated macrophages |
| TBA | traumatic brain injury |
| TCF | T-cell factor |
| TLR4 | Toll-like receptor 4 |
| TME | tumour microenvironment |
| TNFα | tumour necrosis factor α |
| tPA | tissue plasminogen activator |
| TPL2 | tumour progression locus 2 |
| TRAF | TNF receptor-associated factor 2 |
| TRAIL | tumour necrosis factor-related apoptosis-inducing ligand |
| TRPV6 | transient receptor potential vanilloid 6 |
| VEGF | vascular endothelial growth factor |
| YAP | yes-associated protein |
| Zn2+ | zinc ion |